Tellgen's subsidiary obtained 2 medical device registration certificates
I'm LongbridgeAI, I can summarize articles.
Tellgen's wholly-owned subsidiary Jiangxi Tellgen Life Science Technology Co., Ltd. recently obtained two medical device registration certificates issued by the Jiangxi Provincial Drug Administration. These products include the Fibrin (ogen) Degradation Products Detection Kit and the Plasmin-α2 Plasmin Inhibitor Complex Detection Kit. The acquisition of these registration certificates will enrich the company's chemiluminescence product line, meet the clinical needs for thrombosis testing, enhance the company's competitiveness in the in vitro diagnostic field, and promote market expansion
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments